QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01
Published July 24, 2013 · Recall initiated: October 10, 2012
Summary
FDA records drug Class II recall D-802-2013, published July 24, 2013 and initiated October 10, 2012. Recalling firm: American Health Packaging; Status: Terminated; Reported quantity: 19060 blister cards; Lot: Lot 122600 Exp. 03/14. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- American Health Packaging
- Distributor
- Nationwide
- Lot
- Lot 122600 Exp. 03/14
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDACyanocobalamin Injection, USP, 1,000 mcg/mL, Rx Only, 25 x 1mL -Multiple-Dose Vials per carton, Mfg. by:November 11, 2026
- FDAMetoclopramide Tablets, USP, 5 mg, 100 Tablets (10 x 10), Rx Only, Distributed by: American Health Packaging,October 21, 2026
- FDABuprenorphine Sublingual Tablets (C-III), 2 mg, 30 Tablets (3x10), Rx only, Distributed by: American HealthSeptember 9, 2026
- FDANitrofurantoin Capsules, USP (Monohydrate/Macrocrystals), 100 mg, 100 Capsules (10 x 10), 10-count blistersMay 25, 2022
- FDASodium Bicarbonate Powder, CAS-144-55-8, Arm & Hammer, labeled as a) USP5 Grade, packaged in bags of variousJuly 24, 2013
- FDAAmoxicillin for Oral Suspension, USP 200 mg/5 mL, a) 75 mL bottle NDC 0093-4160-78 and b) 100 mL bottle NDCJuly 24, 2013
Questions about this recall
Was QUETIAPINE Fumarate Tablets 25mg 100 Tablets (10x10) Blister card, Rx, Packaged and Distributed by: American Health Packaging, Columbus, Ohio 43217, NDC 68084-530-01 recalled?
Yes. FDA published recall D-802-2013 on July 24, 2013. Reported hazard: Failed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.
What should I do if I have this product?
Voluntary: Firm initiated · Letter